Free Trial

CME Group Inc. (NASDAQ:CME) Shares Sold by Cibc World Markets Corp

CME Group logo with Finance background
Remove Ads

Cibc World Markets Corp lessened its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 18.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 56,855 shares of the financial services provider's stock after selling 12,886 shares during the period. Cibc World Markets Corp's holdings in CME Group were worth $13,203,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Truvestments Capital LLC purchased a new position in shares of CME Group in the 3rd quarter valued at about $26,000. SJS Investment Consulting Inc. grew its position in CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after buying an additional 97 shares during the period. Dunhill Financial LLC grew its position in CME Group by 188.4% during the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider's stock worth $27,000 after buying an additional 81 shares during the period. Financial Life Planners purchased a new position in CME Group in the fourth quarter valued at about $32,000. Finally, Knuff & Co LLC acquired a new stake in shares of CME Group during the 4th quarter valued at approximately $33,000. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Trading Down 1.2 %

CME Group stock traded down $3.19 during trading on Friday, hitting $263.35. The company's stock had a trading volume of 7,238,569 shares, compared to its average volume of 1,925,202. The stock's fifty day moving average is $245.81 and its 200 day moving average is $233.74. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $267.91. The stock has a market capitalization of $94.90 billion, a price-to-earnings ratio of 27.23, a P/E/G ratio of 6.76 and a beta of 0.53.

Remove Ads

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. As a group, equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group declared that its Board of Directors has approved a share buyback program on Thursday, December 5th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to buy up to 3.4% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's board of directors believes its stock is undervalued.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be paid a dividend of $1.25 per share. The ex-dividend date is Friday, March 7th. This is a boost from CME Group's previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a dividend yield of 1.90%. CME Group's payout ratio is currently 51.71%.

Insider Transactions at CME Group

In other news, Director Howard J. Siegel sold 10,000 shares of the stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the sale, the director now owns 21,873 shares of the company's stock, valued at $5,686,980. This represents a 31.37 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the transaction, the insider now owns 21,885 shares in the company, valued at $5,453,085.45. The trade was a 34.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 27,076 shares of company stock worth $6,871,496 in the last ninety days. Insiders own 0.30% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on CME shares. JPMorgan Chase & Co. raised their price objective on CME Group from $209.00 to $212.00 and gave the company an "underweight" rating in a research note on Thursday, February 13th. Piper Sandler raised their price target on CME Group from $250.00 to $258.00 and gave the company an "overweight" rating in a research report on Tuesday, January 7th. Raymond James upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective on the stock in a research report on Monday, March 10th. Barclays raised their target price on shares of CME Group from $257.00 to $263.00 and gave the company an "equal weight" rating in a report on Thursday, February 13th. Finally, Erste Group Bank upgraded shares of CME Group to a "strong-buy" rating in a research report on Monday. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating, three have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $238.93.

Check Out Our Latest Stock Report on CME Group

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads